Clinical Trial

Early Identification and Diagnosis of BAD-related Stroke

Study acronym: SMART-BAD
Recruiting
View on ClinicalTrials.gov →
Summary
Branch atheromatous disease (BAD)-related stroke is an important subtype of acute ischemic stroke involving penetrating arteries and is associated with early neurological deterioration. Early recognition and standardized diagnosis remain challenging in routine clinical practice because clinical symptoms are often non-specific and the diagnosis requires integrated clinical and imaging assessment. This multicenter prospective observational study will collect demographic, clinical, laboratory, electrocardiographic, ultrasound, and multimodal neuroimaging data from adults with acute ischemic stroke within 1 week of symptom onset. Participants will receive routine clinical care determined by their treating physicians; no treatment or management strategy will be assigned by the study protocol. An independent central clinical-imaging adjudication committee will classify participants as BAD-related stroke or non-BAD acute ischemic stroke according to predefined diagnostic criteria. The study aims to develop and externally validate artificial intelligence-assisted screening and diagnostic models for BAD-related stroke and to evaluate their discrimination, calibration, and potential clinical utility.
Trial Details
NCT Number NCT07693816
Lead Sponsor Peking Union Medical College Hospital
Collaborators: Institute of Automation, Chinese Academy of Sciences, Beijing Zhongke Ruiyi Information Technology Co., Ltd.
Conditions Branch Atheromatous Disease, Acute Ischemic Stroke, Cerebral Infarction
Enrollment 1,602 participants
Start Date 2026-07-15
Primary Completion 2028-01-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-09